0001231919-23-000029.txt : 20230511 0001231919-23-000029.hdr.sgml : 20230511 20230511181515 ACCESSION NUMBER: 0001231919-23-000029 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230511 DATE AS OF CHANGE: 20230511 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Taysha Gene Therapies, Inc. CENTRAL INDEX KEY: 0001806310 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 843199512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39536 FILM NUMBER: 23912596 BUSINESS ADDRESS: STREET 1: 3000 PEGASUS PARK DRIVE STREET 2: SUITE 1430 CITY: DALLAS STATE: TX ZIP: 75247 BUSINESS PHONE: (214) 612-0000 MAIL ADDRESS: STREET 1: 3000 PEGASUS PARK DRIVE STREET 2: SUITE 1430 CITY: DALLAS STATE: TX ZIP: 75247 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: McGinnis Emily CENTRAL INDEX KEY: 0001977343 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O TAYSHA GENE THERAPIES, INC. STREET 2: 3000 PEGASUS PARK DRIVE, SUITE 1430 CITY: DALLAS STATE: TX ZIP: 75247 144 1 primary_doc.xml 144 0001977343 XXXXXXXX LIVE 0001806310 Taysha Gene Therapies, Inc. 001-39536 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000 McGinnis Emily Affiliate Common Stock Carta Securities, LLC

333 Bush Street, Floor 23, Ste. 2300 San Francisco CA 94104

19784 41796.75 64178567 05/11/2023 NASDAQ Common Stock 05/11/2023 RSU Award Taysha Gene Therapies, Inc. N 55728 05/11/2023 Cash Y 05/11/2023 /s/ Emily McGinnis